Herbalife Analyst Ratings
Herbalife Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/14/2023 | -7.47% | DA Davidson | → $13.5 | Initiates Coverage On | → Neutral |
| 08/03/2023 | 16.52% | Mizuho | $13 → $17 | Maintains | Neutral |
| 06/07/2023 | -10.9% | Mizuho | → $13 | Initiates Coverage On | → Neutral |
| 03/01/2023 | 91.91% | Citigroup | $26 → $28 | Maintains | Buy |
| 02/03/2023 | -4.04% | B of A Securities | → $14 | Initiates Coverage On | → Underperform |
| 11/01/2022 | 112.47% | B. Riley Securities | $38 → $31 | Maintains | Buy |
| 11/01/2022 | 78.2% | Citigroup | $30 → $26 | Maintains | Buy |
| 10/05/2022 | 105.62% | Citigroup | $36 → $30 | Maintains | Buy |
| 07/12/2022 | — | Jefferies | Upgrades | Hold → Buy | |
| 05/17/2022 | — | Argus Research | Downgrades | Buy → Hold | |
| 05/04/2022 | 181.01% | B. Riley Securities | $50 → $41 | Maintains | Buy |
| 05/04/2022 | 146.74% | Citigroup | $46 → $36 | Maintains | Buy |
| 05/04/2022 | 78.2% | Jefferies | $60 → $26 | Downgrades | Buy → Hold |
| 09/16/2021 | 256.41% | Citigroup | $57 → $52 | Maintains | Buy |
| 06/29/2021 | 379.78% | B. Riley Securities | → $70 | Initiates Coverage On | → Buy |
| 05/08/2020 | 283.82% | Citigroup | $49 → $56 | Maintains | Buy |
| 02/20/2020 | 235.85% | Citigroup | $55 → $49 | Maintains | Buy |
| 12/04/2019 | 276.97% | Citigroup | → $55 | Assumes | → Buy |
| 08/02/2019 | 290.68% | Citigroup | $66 → $57 | Maintains | Buy |
| 10/11/2018 | 345.51% | Jefferies | → $65 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/14/2023 | -7.47% | 达·戴维森 | →$13.5 | 开始承保 | →中性 |
| 08/03/2023 | 16.52% | 瑞穗 | $13→$17 | 维护 | 中性 |
| 06/07/2023 | -10.9% | 瑞穗 | →$13 | 开始承保 | →中性 |
| 03/01/2023 | 91.91% | 花旗集团 | $26→$28 | 维护 | 买 |
| 02/03/2023 | -4.04% | B of A证券 | →$14 | 开始承保 | →表现不佳 |
| 11/01/2022 | 112.47% | B.莱利证券 | $38→$31 | 维护 | 买 |
| 11/01/2022 | 78.2% | 花旗集团 | $30→$26 | 维护 | 买 |
| 10/05/2022 | 105.62% | 花旗集团 | $36→$30 | 维护 | 买 |
| 07/12/2022 | - | 杰富瑞 | 升级 | 持有→购买 | |
| 2022/05/17 | - | Argus研究 | 评级下调 | 购买→Hold | |
| 05/04/2022 | 181.01% | B.莱利证券 | $50→$41 | 维护 | 买 |
| 05/04/2022 | 146.74% | 花旗集团 | $46→$36 | 维护 | 买 |
| 05/04/2022 | 78.2% | 杰富瑞 | $60→$26 | 评级下调 | 购买→Hold |
| 09/16/2021 | 256.41% | 花旗集团 | $57→$52 | 维护 | 买 |
| 2021/06/29 | 379.78% | B.莱利证券 | →$70 | 开始承保 | →购买 |
| 05/08/2020 | 283.82% | 花旗集团 | $49→$56 | 维护 | 买 |
| 02/20/2020 | 235.85% | 花旗集团 | $55→$49 | 维护 | 买 |
| 2019/12/04 | 276.97% | 花旗集团 | →$55 | 假设 | →购买 |
| 2019年08月02日 | 290.68% | 花旗集团 | $66→$57 | 维护 | 买 |
| 2018年10月11日 | 345.51% | 杰富瑞 | →$65 | 开始承保 | →购买 |
What is the target price for Herbalife (HLF)?
康宝莱(Herbalife)的目标价是多少？
The latest price target for Herbalife (NYSE: HLF) was reported by DA Davidson on September 14, 2023. The analyst firm set a price target for $13.50 expecting HLF to fall to within 12 months (a possible -7.47% downside). 8 analyst firms have reported ratings in the last year.
DA Davidson于2023年9月14日报道了康宝莱(纽约证券交易所代码：HLF)的最新目标价。这家分析公司将目标价定为13.50美元，预计HLF将在12个月内跌至(可能下跌7.47%)。去年有8家分析公司公布了评级。
What is the most recent analyst rating for Herbalife (HLF)?
康宝莱(Herbalife)最新的分析师评级是多少？
The latest analyst rating for Herbalife (NYSE: HLF) was provided by DA Davidson, and Herbalife initiated their neutral rating.
康宝莱(纽约证券交易所股票代码：HLF)的最新分析师评级由DA Davidson提供，康宝莱开始对其进行中性评级。
When is the next analyst rating going to be posted or updated for Herbalife (HLF)?
康宝莱(Herbalife)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Herbalife, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Herbalife was filed on September 14, 2023 so you should expect the next rating to be made available sometime around September 14, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与康宝莱的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。康宝莱的上一次评级是在2023年9月14日提交的，因此你应该预计下一次评级将在2024年9月14日左右公布。
Is the Analyst Rating Herbalife (HLF) correct?
分析师对康宝莱(Herbalife)的评级正确吗？
While ratings are subjective and will change, the latest Herbalife (HLF) rating was a initiated with a price target of $0.00 to $13.50. The current price Herbalife (HLF) is trading at is $14.59, which is out of the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的康宝莱(HLF)评级是以0.00美元至13.50美元的目标价启动的。康宝莱目前的股价为14.59美元，超出了分析师的预期区间。